Rankings
▼
Calendar
Sectors
/
Biotechnology
(500 companies)
#
Ticker
Company
Mkt Cap
1
VRTX
Vertex Pharmaceuticals Incorporated
$129B
2
REGN
Regeneron Pharmaceuticals, Inc.
$81B
3
ARGX
argenx SE
$46B
4
ALNY
Alnylam Pharmaceuticals, Inc.
$43B
5
INSM
Insmed Incorporated
$31B
6
UTHR
United Therapeutics Corporation
$24B
7
MRNA
Moderna, Inc.
$22B
8
ROIV
Roivant Sciences Ltd.
$22B
9
RVMD
Revolution Medicines, Inc.
$20B
10
RPRX
Royalty Pharma plc
$20B
11
BNTX
BioNTech SE
$19B
12
INCY
Incyte Corporation
$19B
13
GMAB
Genmab A/S
$17B
14
ASND
Ascendis Pharma A/S
$15B
15
BBIO
BridgeBio Pharma, Inc.
$14B
16
IONS
Ionis Pharmaceuticals, Inc.
$13B
17
SMMT
Summit Therapeutics Inc.
$12B
18
BMRN
BioMarin Pharmaceutical Inc.
$12B
19
JAZZ
Jazz Pharmaceuticals plc
$12B
20
RNAM
Avidity Biosciences Inc
$11B
21
EXEL
Exelixis, Inc.
$11B
22
MDGL
Madrigal Pharmaceuticals, Inc.
$10B
23
AXSM
Axsome Therapeutics, Inc.
$9B
24
PCVX
Vaxcyte, Inc.
$9B
25
TECH
Bio-Techne Corporation
$8B
26
ARWR
Arrowhead Pharmaceuticals, Inc.
$8B
27
IBRX
ImmunityBio, Inc.
$8B
28
HALO
Halozyme Therapeutics, Inc.
$8B
29
CYTK
Cytokinetics, Incorporated
$8B
30
KRYS
Krystal Biotech, Inc.
$8B
31
ABVX
Abivax S.A.
$8B
32
NUVL
Nuvalent, Inc.
$8B
33
KYMR
Kymera Therapeutics, Inc.
$7B
34
PRAX
Praxis Precision Medicines, Inc.
$7B
35
ACLX
Arcellx, Inc.
$7B
36
BLTE
Belite Bio, Inc
$7B
37
RYTM
Rhythm Pharmaceuticals, Inc.
$6B
38
PTGX
Protagonist Therapeutics, Inc.
$6B
39
COGT
Cogent Biosciences, Inc.
$6B
40
PTCT
PTC Therapeutics, Inc.
$6B
41
CELC
Celcuity Inc.
$5B
42
IMVT
Immunovant, Inc.
$5B
43
CGON
CG Oncology, Inc. Common stock
$5B
44
CAI
Caris Life Sciences, Inc.
$5B
45
CRSP
CRISPR Therapeutics AG
$5B
46
ERAS
Erasca, Inc.
$5B
47
ALKS
Alkermes plc
$5B
48
XENE
Xenon Pharmaceuticals Inc.
$5B
49
TGTX
TG Therapeutics, Inc.
$5B
50
SRRK
Scholar Rock Holding Corporation
$5B
51
MIRM
Mirum Pharmaceuticals, Inc.
$5B
52
FOLD
Amicus Therapeutics, Inc.
$5B
53
LGND
Ligand Pharmaceuticals Incorporated
$4B
54
APGE
Apogee Therapeutics, Inc.
$4B
55
TERN
Terns Pharmaceuticals, Inc.
$4B
56
VKTX
Viking Therapeutics, Inc.
$4B
57
CRNX
Crinetics Pharmaceuticals, Inc.
$4B
58
ACAD
ACADIA Pharmaceuticals Inc.
$4B
59
ADMA
ADMA Biologics, Inc.
$4B
60
CNTA
Centessa Pharmaceuticals plc
$4B
61
CORT
Corcept Therapeutics Incorporated
$4B
62
KNSA
Kiniksa Pharmaceuticals, Ltd.
$3B
63
NAMS
NewAmsterdam Pharma Company N.V.
$3B
64
DNLI
Denali Therapeutics Inc.
$3B
65
GPCR
Structure Therapeutics Inc.
$3B
66
LQDA
Liquidia Corporation
$3B
67
DYN
Dyne Therapeutics, Inc.
$3B
68
EWTX
Edgewise Therapeutics, Inc.
$3B
69
CPRX
Catalyst Pharmaceuticals, Inc.
$3B
70
TARS
Tarsus Pharmaceuticals, Inc.
$3B
71
ARQT
Arcutis Biotherapeutics, Inc.
$3B
72
IDYA
IDEAYA Biosciences, Inc.
$3B
73
VERA
Vera Therapeutics, Inc.
$3B
74
DNTH
Dianthus Therapeutics, Inc.
$3B
75
ALMS
Alumis Inc. Common Stock
$3B
76
BEAM
Beam Therapeutics Inc.
$3B
77
TLX
Telix Pharmaceuticals Limited
$3B
78
TVTX
Travere Therapeutics, Inc.
$3B
79
VCYT
Veracyte, Inc.
$3B
80
WVE
Wave Life Sciences Ltd.
$3B
81
SYRE
Spyre Therapeutics, Inc.
$3B
82
VRDN
Viridian Therapeutics, Inc.
$3B
83
APLS
Apellis Pharmaceuticals, Inc.
$3B
84
IRON
Disc Medicine, Inc.
$2B
85
RCUS
Arcus Biosciences, Inc.
$2B
86
MAZE
Maze Therapeutics, Inc.
$2B
87
RNA
Avidity Biosciences, Inc.
$2B
88
ADPT
Adaptive Biotechnologies Corporation
$2B
89
STOK
Stoke Therapeutics, Inc.
$2B
90
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
$2B
91
GLPG
Galapagos N.V.
$2B
92
RARE
Ultragenyx Pharmaceutical Inc.
$2B
93
DAWN
Day One Biopharmaceuticals, Inc.
$2B
94
OCUL
Ocular Therapeutix, Inc.
$2B
95
ZLAB
Zai Lab Limited
$2B
96
SNDX
Syndax Pharmaceuticals, Inc.
$2B
97
SLNO
Soleno Therapeutics, Inc.
$2B
98
CLDX
Celldex Therapeutics, Inc.
$2B
99
MESO
Mesoblast Limited
$2B
100
ZYME
Zymeworks Inc.
$2B
101
AUPH
Aurinia Pharmaceuticals Inc.
$2B
102
TNGX
Tango Therapeutics, Inc.
$2B
103
IMNM
Immunome, Inc.
$2B
104
RLAY
Relay Therapeutics, Inc.
$2B
105
NBTX
Nanobiotix S.A.
$2B
106
MLYS
Mineralys Therapeutics, Inc.
$2B
107
SRPT
Sarepta Therapeutics, Inc.
$2B
108
BCRX
BioCryst Pharmaceuticals, Inc.
$2B
109
TYRA
Tyra Biosciences, Inc.
$2B
110
MANE
Veradermics, Incorporated
$2B
111
ELVN
Enliven Therapeutics, Inc.
$2B
112
LEGN
Legend Biotech Corporation
$2B
113
NVAX
Novavax, Inc.
$2B
114
SION
Sionna Therapeutics, Inc.
$2B
115
PHVS
Pharvaris N.V.
$2B
116
IOVA
Iovance Biotherapeutics, Inc.
$2B
117
ANAB
AnaptysBio, Inc.
$2B
118
IMCR
Immunocore Holdings plc
$2B
119
AGIO
Agios Pharmaceuticals, Inc.
$2B
120
VCEL
Vericel Corporation
$2B
121
HRMY
Harmony Biosciences Holdings, Inc.
$2B
122
PVLA
Palvella Therapeutics, Inc.
$2B
123
NUVB
Nuvation Bio Inc.
$2B
124
NTLA
Intellia Therapeutics, Inc.
$2B
125
OCS
Oculis Holding AG
$2B
126
CAPR
Capricor Therapeutics, Inc.
$2B
127
RXRX
Recursion Pharmaceuticals, Inc.
$2B
128
ARDX
Ardelyx, Inc.
$1B
129
TRVI
Trevi Therapeutics, Inc.
$1B
130
INVA
Innoviva, Inc.
$1B
131
MNMD
Mind Medicine (MindMed) Inc.
$1B
132
NKTR
Nektar Therapeutics
$1B
133
VIR
Vir Biotechnology, Inc.
$1B
134
KOD
Kodiak Sciences Inc.
$1B
135
CRVS
Corvus Pharmaceuticals, Inc.
$1B
136
NRIX
Nurix Therapeutics, Inc.
$1B
137
IMTX
Immatics N.V.
$1B
138
EYPT
EyePoint Pharmaceuticals, Inc.
$1B
139
OLMA
Olema Pharmaceuticals, Inc.
$1B
140
ORKA
Oruka Therapeutics, Inc.
$1B
141
MLTX
MoonLake Immunotherapeutics
$1B
142
SEPN
Septerna, Inc.
$1B
143
ORIC
ORIC Pharmaceuticals, Inc.
$1B
144
AMLX
Amylyx Pharmaceuticals, Inc.
$1B
145
SVRA
Savara Inc.
$1B
146
GLUE
Monte Rosa Therapeutics, Inc.
$1B
147
QURE
uniQure N.V.
$1B
148
RAPP
Rapport Therapeutics, Inc. Common Stock
$1B
149
PHAR
Pharming Group N.V.
$1B
150
BHVN
Biohaven Ltd.
$1B
151
ZBIO
Zenas BioPharma, Inc.
$1B
152
TSHA
Taysha Gene Therapies, Inc.
$1B
153
ABCL
AbCellera Biologics Inc.
$1B
154
AVBP
ArriVent BioPharma, Inc. Common Stock
$1B
155
INBX
Inhibrx Biosciences, Inc.
$1B
156
PGEN
Precigen, Inc.
$1B
157
BCAX
Bicara Therapeutics Inc. Common Stock
$1B
158
GERN
Geron Corporation
$1B
159
AKTS
Aktis Oncology, Inc.
$1B
160
GHRS
GH Research PLC
$1B
161
VTYX
Ventyx Biosciences, Inc.
$1B
162
MRVI
Maravai LifeSciences Holdings, Inc.
$999M
163
MBX
MBX Biosciences, Inc. Common Stock
$986M
164
VALN
Valneva SE
$981M
165
XERS
Xeris Biopharma Holdings, Inc.
$960M
166
RAPT
RAPT Therapeutics, Inc.
$959M
167
URGN
UroGen Pharma Ltd.
$927M
168
ABUS
Arbutus Biopharma Corporation
$926M
169
SPRY
ARS Pharmaceuticals, Inc.
$913M
170
ARVN
Arvinas, Inc.
$907M
171
KALV
KalVista Pharmaceuticals, Inc.
$905M
172
SGP
SpyGlass Pharma, Inc. Common Stock
$900M
173
SANA
Sana Biotechnology, Inc.
$900M
174
PHAT
Phathom Pharmaceuticals, Inc.
$891M
175
XNCR
Xencor, Inc.
$890M
176
JANX
Janux Therapeutics, Inc.
$852M
177
FTRE
Fortrea Holdings Inc.
$851M
178
CTMX
CytomX Therapeutics, Inc.
$846M
179
OMER
Omeros Corporation
$835M
180
SLS
SELLAS Life Sciences Group, Inc.
$829M
181
BBOT
BridgeBio Oncology Therapeutics Inc.
$820M
182
KURA
Kura Oncology, Inc.
$815M
183
MNKD
MannKind Corporation
$813M
184
CMPX
Compass Therapeutics, Inc.
$781M
185
PRME
Prime Medicine, Inc.
$771M
186
GYRE
Gyre Therapeutics, Inc.
$762M
187
BIOA
BioAge Labs, Inc.
$755M
188
PROK
ProKidney Corp.
$722M
189
TBPH
Theravance Biopharma, Inc.
$716M
190
ANNX
Annexon, Inc.
$713M
191
REPL
Replimune Group, Inc.
$712M
192
LXRX
Lexicon Pharmaceuticals, Inc.
$704M
193
MDXG
MiMedx Group, Inc.
$684M
194
ANRO
Alto Neuroscience, Inc.
$667M
195
SLDB
Solid Biosciences Inc.
$644M
196
MGTX
MeiraGTx Holdings plc
$637M
197
TECX
Tectonic Therapeutic, Inc.
$635M
198
DRUG
Bright Minds Biosciences Inc.
$631M
199
ZVRA
Zevra Therapeutics, Inc.
$618M
200
LBRX
LB Pharmaceuticals Inc Common Stock
$617M
201
ALLO
Allogene Therapeutics, Inc.
$600M
202
ADCT
ADC Therapeutics S.A.
$591M
203
NMRA
Neumora Therapeutics, Inc. Common Stock
$586M
204
VNDA
Vanda Pharmaceuticals Inc.
$585M
205
DRTS
Alpha Tau Medical Ltd.
$580M
206
OCGN
Ocugen, Inc.
$578M
207
RCKT
Rocket Pharmaceuticals, Inc.
$572M
208
DSGN
Design Therapeutics, Inc.
$569M
209
LYEL
Lyell Immunopharma, Inc.
$561M
210
DBVT
DBV Technologies S.A.
$560M
211
IMMX
Immix Biopharma, Inc.
$559M
212
YDES
YD Bio Limited Ordinary Shares
$554M
213
PRTA
Prothena Corporation plc
$549M
214
RIGL
Rigel Pharmaceuticals, Inc.
$541M
215
CRMD
CorMedix Inc.
$536M
216
LXEO
Lexeo Therapeutics, Inc. Common Stock
$533M
217
CLYM
Climb Bio, Inc.
$522M
218
RGNX
REGENXBIO Inc.
$517M
219
RLMD
Relmada Therapeutics, Inc.
$513M
220
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
$504M
221
TRDA
Entrada Therapeutics, Inc.
$502M
222
AVIR
Atea Pharmaceuticals, Inc.
$501M
223
LRMR
Larimar Therapeutics, Inc.
$497M
224
JBIO
Jade Biosciences, Inc.
$491M
225
ASMB
Assembly Biosciences, Inc.
$475M
226
ETON
Eton Pharmaceuticals, Inc.
$471M
227
ZURA
Zura Bio Limited
$468M
228
FDMT
4D Molecular Therapeutics, Inc.
$468M
229
GNFT
Genfit S.A.
$446M
230
AVXL
Anavex Life Sciences Corp.
$441M
231
AUTL
Autolus Therapeutics plc
$439M
232
FULC
Fulcrum Therapeutics, Inc.
$436M
233
PEPG
PepGen Inc.
$435M
234
NAGE
Niagen Bioscience Inc
$423M
235
KYTX
Kyverna Therapeutics, Inc.
$420M
236
DNA
Ginkgo Bioworks Holdings, Inc.
$418M
237
DMAC
DiaMedica Therapeutics Inc.
$418M
238
KROS
Keros Therapeutics, Inc.
$414M
239
PRTC
PureTech Health plc
$411M
240
IMMP
Immutep Limited
$406M
241
MNPR
Monopar Therapeutics Inc.
$397M
242
CLLS
Cellectis S.A.
$390M
243
VSTM
Verastem, Inc.
$388M
244
LENZ
LENZ Therapeutics, Inc.
$387M
245
GLSI
Greenwich LifeSciences, Inc.
$385M
246
ABSI
Absci Corporation
$384M
247
NBP
NovaBridge Biosciences
$383M
248
BCYC
Bicycle Therapeutics plc
$374M
249
FBRX
Forte Biosciences, Inc.
$374M
250
AKBA
Akebia Therapeutics, Inc.
$365M
251
AURA
Aura Biosciences, Inc.
$361M
252
NGNE
Neurogene Inc.
$360M
253
ENGN
enGene Holdings Inc.
$359M
254
ALT
Altimmune, Inc.
$353M
255
IRD
Opus Genetics, Inc.
$349M
256
XOMA
XOMA Royalty Corp.
$347M
257
CBIO
Crescent Biopharma, Inc.
$345M
258
NAUT
Nautilus Biotechnology, Inc.
$339M
259
IVA
Inventiva S.A.
$332M
260
FHTX
Foghorn Therapeutics Inc.
$330M
261
NGEN
NervGen Pharma Corp. Common stock
$328M
262
ENTA
Enanta Pharmaceuticals, Inc.
$327M
263
CABA
Cabaletta Bio, Inc.
$325M
264
BNTC
Benitec Biopharma Inc.
$324M
265
EVMN
Evommune, Inc.
$319M
266
ALDX
Aldeyra Therapeutics, Inc.
$318M
267
PBYI
Puma Biotechnology, Inc.
$311M
268
XOMAP
XOMA Corporation
$311M
269
AMRN
Amarin Corporation plc
$310M
270
RZLT
Rezolute, Inc.
$310M
271
ACIU
AC Immune S.A.
$299M
272
SLN
Silence Therapeutics plc
$296M
273
STTK
Shattuck Labs, Inc.
$291M
274
CADL
Candel Therapeutics, Inc.
$288M
275
IMAB
I-Mab
$287M
276
HELP
Cybin Inc. Common Stock
$285M
277
ANL
Adlai Nortye Ltd.
$284M
278
ABEO
Abeona Therapeutics Inc.
$283M
279
ALEC
Alector, Inc.
$275M
280
CNTX
Context Therapeutics Inc.
$273M
281
PALI
Palisade Bio, Inc.
$272M
282
VYGR
Voyager Therapeutics, Inc.
$270M
283
OBIO
Orchestra BioMed Holdings, Inc.
$267M
284
EPRX
Eupraxia Pharmaceuticals Inc.
$267M
285
NVCT
Nuvectis Pharma, Inc.
$259M
286
IVVD
Invivyd, Inc.
$257M
287
EDIT
Editas Medicine, Inc.
$256M
288
IPSC
Century Therapeutics, Inc.
$250M
289
CCCC
C4 Therapeutics, Inc.
$243M
290
SRZN
Surrozen, Inc.
$239M
291
SLGL
Sol-Gel Technologies Ltd.
$234M
292
ACHV
Achieve Life Sciences, Inc.
$233M
293
OABI
OmniAb, Inc.
$231M
294
TARA
Protara Therapeutics, Inc.
$228M
295
CHRS
Coherus Oncology, Inc.
$226M
296
FENC
Fennec Pharmaceuticals Inc.
$220M
297
ELTX
Elicio Therapeutics, Inc.
$220M
298
GALT
Galectin Therapeutics Inc.
$218M
299
RNAC
Cartesian Therapeutics, Inc.
$218M
300
ARCT
Arcturus Therapeutics Holdings Inc.
$217M
301
CBUS
Cibus, Inc.
$216M
302
STRO
Sutro Biopharma, Inc.
$216M
303
QSI
Quantum-Si incorporated
$212M
304
IMRX
Immuneering Corporation
$206M
305
CGEN
Compugen Ltd.
$202M
306
PLYX
Polaryx Therapeutics, Inc. Common Stock
$200M
307
WHWK
Whitehawk Therapeutics Inc
$198M
308
ABOS
Acumen Pharmaceuticals, Inc.
$197M
309
MGNX
MacroGenics, Inc.
$196M
310
ZNTL
Zentalis Pharmaceuticals, Inc.
$196M
311
PRQR
ProQR Therapeutics N.V.
$195M
312
NTHI
Neonc Technologies Holdings, Inc.
$194M
313
AVTX
Avalo Therapeutics, Inc.
$194M
314
MDWD
MediWound Ltd.
$189M
315
PRLD
Prelude Therapeutics Incorporated
$189M
316
KLRS
Kalaris Therapeutics Inc
$187M
317
CNTN
Tharimmune, Inc.
$186M
318
CRBU
Caribou Biosciences, Inc.
$186M
319
NKTX
Nkarta, Inc.
$186M
320
ELDN
Eledon Pharmaceuticals, Inc.
$185M
321
TNXP
Tonix Pharmaceuticals Holding Corp.
$184M
322
MOLN
Molecular Partners AG
$183M
323
VXRT
Vaxart, Inc.
$182M
324
HUMA
Humacyte, Inc.
$180M
325
MENS
Jyong Biotech Ltd. Ordinary Shares
$178M
326
THAR
Tharimmune, Inc.
$177M
327
SGMT
Sagimet Biosciences Inc.
$175M
328
ALPS
Alps Group Inc
$169M
329
HRTX
Heron Therapeutics, Inc.
$162M
330
CNTB
Connect Biopharma Holdings Limited
$159M
331
OVID
Ovid Therapeutics Inc.
$158M
332
FATE
Fate Therapeutics, Inc.
$158M
333
TNYA
Tenaya Therapeutics, Inc.
$157M
334
IMDX
Insight Molecular Diagnostics Inc.
$154M
335
SGMO
Sangamo Therapeutics, Inc.
$154M
336
UNCY
Unicycive Therapeutics, Inc.
$151M
337
IPHA
Innate Pharma S.A.
$148M
338
MIST
Milestone Pharmaceuticals Inc.
$147M
339
IKT
Inhibikase Therapeutics, Inc.
$140M
340
ARTV
Artiva Biotherapeutics, Inc.
$140M
341
CRDF
Cardiff Oncology, Inc.
$139M
342
SPRO
Spero Therapeutics, Inc.
$135M
343
IMUX
Immunic, Inc.
$135M
344
ORMP
Oramed Pharmaceuticals Inc.
$132M
345
AARD
Aardvark Therapeutics, Inc. Common Stock
$131M
346
ANTX
AN2 Therapeutics, Inc.
$127M
347
BDTX
Black Diamond Therapeutics, Inc.
$126M
348
CAMP
CAMP4 Therapeutics Corporation
$125M
349
GOSS
Gossamer Bio, Inc.
$124M
350
CRBP
Corbus Pharmaceuticals Holdings, Inc.
$124M
351
ADAG
Adagene Inc.
$123M
352
SAVA
Cassava Sciences, Inc.
$116M
353
AGEN
Agenus Inc.
$116M
354
KRRO
Korro Bio, Inc.
$115M
355
CDXS
Codexis, Inc.
$114M
356
VOR
Vor Biopharma Inc.
$113M
357
ALXO
ALX Oncology Holdings Inc.
$112M
358
GANX
Gain Therapeutics, Inc.
$108M
359
GNLX
Genelux Corporation
$107M
360
FBIO
Fortress Biotech, Inc.
$106M
361
TTRX
Turn Therapeutics Inc.
$104M
362
ONCY
Oncolytics Biotech Inc.
$103M
363
RANI
Rani Therapeutics Holdings, Inc.
$102M
364
SEER
Seer, Inc.
$101M
365
ANIX
Anixa Biosciences, Inc.
$100M
366
HURA
TuHURA Biosciences, Inc.
$99M
367
VTVT
vTv Therapeutics Inc.
$95M
368
PYXS
Pyxis Oncology, Inc.
$94M
369
INO
Inovio Pharmaceuticals, Inc.
$94M
370
ATYR
aTyr Pharma, Inc.
$93M
371
BMEA
Biomea Fusion, Inc.
$88M
372
PMVP
PMV Pharmaceuticals, Inc.
$88M
373
PLRX
Pliant Therapeutics, Inc.
$85M
374
CGTX
Cognition Therapeutics, Inc.
$85M
375
COYA
Coya Therapeutics, Inc.
$83M
376
MCRB
Seres Therapeutics, Inc.
$82M
377
CSBR
Champions Oncology, Inc.
$82M
378
TLSA
Tiziana Life Sciences Ltd
$82M
379
ACET
Adicet Bio, Inc.
$76M
380
KPTI
Karyopharm Therapeutics Inc.
$74M
381
QTTB
Q32 Bio Inc.
$73M
382
XBIT
XBiotech Inc.
$72M
383
ACTU
Actuate Therapeutics Inc
$70M
384
EQ
Equillium, Inc.
$69M
385
MNOV
MediciNova, Inc.
$69M
386
DTIL
Precision BioSciences, Inc.
$69M
387
OKYO
OKYO Pharma Limited
$69M
388
TCRX
TScan Therapeutics, Inc.
$69M
389
MGX
Metagenomi, Inc. Common Stock
$67M
390
IMA
ImageneBio Inc
$67M
391
IFRX
InflaRx N.V.
$66M
392
ENTX
Entera Bio Ltd.
$66M
393
NRXS
NeurAxis, Inc.
$65M
394
EXOZ
eXoZymes, Inc.
$64M
395
MREO
Mereo BioPharma Group plc
$64M
396
INKT
MiNK Therapeutics, Inc.
$63M
397
BYSI
BeyondSpring Inc.
$62M
398
TIL
Instil Bio, Inc.
$62M
399
HYFT
MindWalk Holdings Corp.
$61M
400
ICCC
ImmuCell Corporation
$60M
401
TENX
Tenax Therapeutics, Inc.
$59M
402
NERV
Minerva Neurosciences, Inc.
$58M
403
GRCE
Grace Therapeutics, Inc.
$57M
404
VRCA
Verrica Pharmaceuticals Inc.
$56M
405
EDSA
Edesa Biotech, Inc.
$55M
406
RLYB
Rallybio Corporation
$54M
407
ESLA
Estrella Immunopharma, Inc.
$53M
408
ACRV
Acrivon Therapeutics, Inc. Common Stock
$53M
409
NTRB
Nutriband Inc.
$53M
410
ANVS
Annovis Bio, Inc.
$53M
411
XFOR
X4 Pharmaceuticals, Inc.
$52M
412
KZR
Kezar Life Sciences, Inc.
$52M
413
CLNN
Clene Inc.
$51M
414
OKUR
OnKure Therapeutics, Inc.
$49M
415
ELUT
Elutia Inc.
$48M
416
ATRA
Atara Biotherapeutics, Inc.
$47M
417
LPCN
Lipocine Inc.
$46M
418
GLTO
Galecto, Inc.
$46M
419
TELO
Telomir Pharmaceuticals, Inc. Common Stock
$46M
420
COEP
Coeptis Therapeutics, Inc.
$46M
421
ALGS
Aligos Therapeutics, Inc.
$45M
422
LSTA
Lisata Therapeutics, Inc.
$44M
423
EIKN
Eikon Therapeutics, Inc. Common Stock
$44M
424
LITS
Lite Strategy, Inc.
$44M
425
PYPD
PolyPid Ltd.
$44M
426
CING
Cingulate Inc.
$43M
427
CRVO
CervoMed Inc.
$43M
428
ATOS
Atossa Therapeutics, Inc.
$41M
429
VERU
Veru Inc.
$41M
430
IBIO
iBio, Inc.
$40M
431
SABS
SAB Biotherapeutics, Inc.
$39M
432
SNSE
Sensei Biotherapeutics, Inc.
$39M
433
SPRB
Spruce Biosciences, Inc.
$38M
434
PDSB
PDS Biotechnology Corporation
$38M
435
TVRD
Tvardi Therapeutics, Inc.
$37M
436
BTAI
BioXcel Therapeutics, Inc.
$37M
437
NXTC
NextCure, Inc.
$36M
438
INMB
INmune Bio, Inc.
$35M
439
HOWL
Werewolf Therapeutics, Inc.
$35M
440
GUTS
Fractyl Health, Inc. Common Stock
$35M
441
ATHE
Alterity Therapeutics Limited
$32M
442
CYPH
Cypherpunk Technologies Inc.
$32M
443
CELU
Celularity Inc.
$32M
444
TVGN
Tevogen Bio Holdings Inc.
$32M
445
NRXP
NRx Pharmaceuticals, Inc.
$32M
446
LTRN
Lantern Pharma Inc.
$31M
447
PMN
ProMIS Neurosciences, Inc.
$30M
448
PLUR
Pluri Inc.
$30M
449
RNXT
RenovoRx, Inc.
$29M
450
PASG
Passage Bio, Inc.
$29M
451
XLO
Xilio Therapeutics, Inc.
$28M
452
ENLV
Enlivex Therapeutics Ltd.
$28M
453
DYAI
Dyadic International, Inc.
$28M
454
KLTO
Klotho Neurosciences, Inc.
$27M
455
SNTI
Senti Biosciences, Inc.
$26M
456
XCUR
Exicure, Inc.
$26M
457
CUE
Cue Biopharma, Inc.
$26M
458
BOLD
Boundless Bio, Inc.
$26M
459
LONA
LeonaBio, Inc.
$26M
460
SKYE
Skye Bioscience, Inc.
$24M
461
LPTX
Leap Therapeutics, Inc.
$23M
462
BRNS
Barinthus Biotherapeutics plc
$23M
463
JSPR
Jasper Therapeutics, Inc.
$23M
464
APLM
Apollomics, Inc.
$22M
465
NRSN
NeuroSense Therapeutics Ltd.
$21M
466
ABVC
ABVC BioPharma, Inc.
$21M
467
IOBT
IO Biotech, Inc.
$21M
468
ALLR
Allarity Therapeutics, Inc.
$21M
469
VTGN
VistaGen Therapeutics, Inc.
$20M
470
EVAX
Evaxion Biotech A/S
$20M
471
LGVN
Longeveron Inc.
$20M
472
PSTV
Plus Therapeutics, Inc.
$19M
473
CVKD
Cadrenal Therapeutics, Inc. Common Stock
$19M
474
ANEB
Anebulo Pharmaceuticals, Inc.
$18M
475
OTLK
Outlook Therapeutics, Inc.
$18M
476
TAOX
TAO Synergies Inc.
$17M
477
FBLG
FibroBiologics, Inc. Common Stock
$17M
478
GNTA
Genenta Science S.p.A.
$17M
479
MRKR
Marker Therapeutics, Inc.
$16M
480
MPLT
MapLight Therapeutics, Inc.
$16M
481
HIND
Vyome Holdings, Inc.
$15M
482
CRIS
Curis, Inc.
$15M
483
INTS
Intensity Therapeutics, Inc.
$15M
484
DARE
Daré Bioscience, Inc.
$15M
485
LEXX
Lexaria Bioscience Corp.
$14M
486
JUNS
Jupiter Neurosciences, Inc.
$14M
487
PLRZ
Polyrizon Ltd.
$14M
488
KZIA
Kazia Therapeutics Limited
$14M
489
PHIO
Phio Pharmaceuticals Corp.
$13M
490
HOTH
Hoth Therapeutics, Inc.
$13M
491
OSRH
OSR Holdings, Inc.
$13M
492
CMMB
Chemomab Therapeutics Ltd.
$12M
493
NCNA
NuCana plc
$12M
494
SNGX
Soligenix, Inc.
$12M
495
GDTC
CytoMed Therapeutics Limited
$12M
496
BLRX
BioLineRx Ltd.
$12M
497
MDCX
Medicus Pharma Ltd. Common Stock
$12M
498
LIXT
Lixte Biotechnology Holdings, Inc.
$12M
499
CURX
Curanex Pharmaceuticals Inc Common Stock
$12M
500
CTXR
Citius Pharmaceuticals, Inc.
$11M